Our approach to Quality Management ensures that we’re always speaking the same language. When it comes to needing a Quality Management Solution, there are numerous benefits to working with a CDMO like Veranex. We have the flexibility to adapt to the client’s needs...
Built to Fit Your Needs: Our CDMO Capabilities
Learn about our capabilities and offerings as a CDMO We sat down with Bill Croisetiere (VP, Integrated Supply Chain), Chris Vigneau (VP, Manufacturing Solutions) to discuss our unique approach to manufacturing as a CDMO. Being both horizontally and vertically...
Artificial Intelligence (AI), General Data Protection Regulation (GDPR) and Cybersecurity: 10 Misconceptions About Medical Device Software
Medical Device Software (MDSW) is a growing, fast-evolving industry. However, manufacturers must often face a regulatory framework which does not evolve at the same speed. Regulation for medical devices is restrictive, since it needs to guarantee the safety...
Key Insights from NMPA Guidance Draft 01 & 02 from Our Human Factors Team
The human factors team at Veranex has reviewed the NMPA Guidance Draft 01 and Draft 02 and submitted feedback to the agency. We're committed to helping you stay informed about the latest updates and clarifications in the ever-evolving regulatory landscape. Here's a...
Bridging Design and Manufacturing
For growth-stage companies, finding a contract manufacturer to take on low volume runs and bridge the gap between design and manufacturing can be a challenge. Especially where time and cashflow is concerned, it’s critical to work with a partner that can seamlessly...
Event Recap: Biocompatibility Insights 2023
This year’s Biocompatibility Insights conference took place in Annapolis, MD, US from September 25–27, 2023. The framework for the event was “Exploring the science behind the regulations” with the sub theme “Addressing challenges in medical device toxicology. Keynote...
Preclinical Insights #38 – What Sets Us Apart: Our In-House Pathology Department
Veranex is proud to share the latest issue of our Preclinical Insights publication. In this issue we talk with Dr. Laurence Fiette, Head of Veranex’s Pathology Department.Dr. Laurence Fiette, Head of Veranex’s Pathology Department. With Veranex for 16 years, she...
Preclinical Insights #39 — 25 Years of Preclinical Paris: A Conversation with Our Founders
Veranex is proud to share the latest issue of our Preclinical Insights publication. In this issue we talk with Preclinical Paris Founders Nicolas Borenstein and Luc Behr on the changes they've experienced over the past 25 years, the legacy they've created, and trends...
Preclinical Insights #40 — Have a Heart
Veranex is proud to share the latest issue of our Preclinical Insights publication. Our state-of-the-art facilities in both Atlanta and Paris, innovative spirit, and passion for advancing medical technologies make us experts in preclinical vascular research, helping...
A Bird’s Eye View of the Nuclear Medicine and Radiopharmaceuticals Market in China
Part 1: Providers and Regulators Getting information on the nuclear medicine market landscape, regulations, and market access environment in China can be challenging — especially due to its specialized nature within clinical practice. In this article, Betty Su, our...